Navigation Links
J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
Date:4/23/2009

FLORHAM PARK, N.J., April 23 /PRNewswire/ -- OTC Perspectives - a new division within the leading pharmaceutical conference and consulting company DTC Perspectives Inc. - has announced the finalists for the 2009 OTC National Advertising Awards. Among the leading healthcare brands named as finalists are Aleve, Benadryl, Claritin, Mucinex, MiraLAX, Neutrogena, and Zyrtec (see details below).

All winners of OTC National Advertising Awards will be announced June 4, 2009, at a celebratory reception at the debut OTC National Conference (June 4-5 in Boston). Among the highlights of the conference are keynote addresses by Rex Briggs, author of the acclaimed marketing book "What Sticks"; Mike Bloxham, from the Center for Media Design at Ball State University; and Bob Garfield, who will address the "Brave New Media World."

"The delegates attending the OTC National Conference will determine the winners for Best Branded TV Campaign," Bob Ehrlich, CEO of DTC Perspectives noted. Independent expert panels determined award winners in other categories.

"We congratulate the finalists for their creative, effective campaigns," said OTC Perspectives Magazine editor Mark Tosh.

Finalists for each of the categories are listed below:

                            Best Branded TV Finalists*
    Brand             Manufacturer                  Advertising Agency

    Aleve             Bayer                         Energy BBDO
    Benefiber         Novartis Consumer Health      Euro RSCG
    Benadryl          McNeil Consumer Healthcare    JWT New York
    Claritin          Schering-Plough               Euro RSCG Tonic
    Ensure            Abbott Nutrition              Abelson Taylor
    MiraLAX           Schering-Plough               Merkley & Partners
    Mucinex           Reckitt Benckiser             Reckitt Benckiser
    Neutrogena        Neutrogena                    Roberts & Tarlow
    SkinID
    Sarna             Steifel Laboratories          Adair Greene McCann
    Theraflu          Novartis Consumer Health      Saatchi & Saatchi
                                                    Consumer Health +
                                                    Wellness

    *Winners to be Selected by OTC National Delegate Vote on June 4, 2009

                    Best Branded Print - Top 3 Finalists
    Brand             Manufacturer                  Advertising Agency

    Claritin          Schering-Plough               Euro RSCG Tonic
    Mucinex           Reckitt Benckiser             Reckitt Benckiser
    ZYRTEC            McNeil Consumer               JWT New York
                      Healthcare

             Best Branded Integrated Finalists - Top 3 Finalists
    Brand             Manufacturer                  Advertising Company

    Benadryl          McNeil Consumer               JWT New York
                      Healthcare
    Claritin          Schering-Plough               Euro RSCG Tonic
    Mucinex           Reckitt Benckiser             Reckitt Benckiser

About The OTC National Conference

The OTC National is the premier marketing conference for healthcare marketers and is designed to deliver actionable insights and unprecedented networking opportunities to delegates.

For more information about the OTC National Advertising Awards, or to register for the conference, contact Scott Ehrlich, Director of Business Development, at 770-559-0702 / scott@dtcperspectives.com or visit www.otcperspectives.com.


'/>"/>
SOURCE The OTC National Conference
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
2. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
3. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
4. Bayer HealthCare Cleared to Acquire Citracal(R)
5. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
6. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
7. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
8. Bayer Temporarily Suspends Global Trasylol(R) Marketing
9. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
10. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
11. Bayer Awards Making Science Make Sense Grant to Girl Scouts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company ... NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic ... organizations that have excellent programs for the delivery and improvement of disease management ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The American ... 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management ... who have contributed not only to the association, but also to the Health Care ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... On Wednesday, March 22, ... at 5,821.64, up 0.48%; the Dow Jones Industrial ... and the S&P 500 closed at 2,348.45, slightly ... out of nine sectors ended the day in ... on the following Medical Instruments & Supplies equities: ...
(Date:3/23/2017)... 2017 Piramal Pharma ... gibt die Ernennung von Stuart E. Needleman ... globalen Pharmazeutikkunden eine einmalige integrierte End-to-End-Serviceplattform an ... für das erfolgreiche Wachstum und die Umsetzung ... Herr Needleman dafür verantwortlich sein, alle globalen ...
(Date:3/23/2017)... 23, 2017 Merrimack Pharmaceuticals, Inc. (NASDAQ: ... patient in a Phase 1 study of MM-310 in ... encapsulates a novel taxane and targets the EphA2 receptor, ... of many major tumor types, including prostate, ovarian, bladder, ... of this study is an important step in evaluating ...
Breaking Medicine Technology: